First targeted therapy for rare mutation of gastrointestinal stromal tumorsThe U.S. Food and Drug Administration (FDA) recently announced the approval of Blueprint Medicines Corporation’s avapritinib (Ayvakit) for the treatment…
Scientists can silence inflammatory gene responsible for a form of breast cancerScientists have found that they are able to “switch off,” or silence, a gene that is responsible for an aggressive…